Raninier Clinical Reserach — Renton, Washington

Raninier Clinical Reserach is a clinical research site located in Renton, Washington, United States 98057.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Raninier Clinical Reserach has participated in 1 clinical trials.

Therapeutic areas: Hyperlipidemia.

Sponsors: Arisaph Pharmaceuticals Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Renton

Browse all research sites in Washington · View every site in Renton

• University of Washington
• University of Washington Valley Medical Center
• Public Hospital of King County District 1 Valley Medical Center
• Valley Medical Center
• Rainier Clinical Research Center
• Research Site
• Novo Nordisk Investigational Site
• Rainier Clin Res Ctr Inc
• GSK Investigational Site
• Rainier Clinical Research
• Pfizer Investigational Site
• Rainer Clinical Research Center

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Raninier Clinical Reserach?

Raninier Clinical Reserach has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Raninier Clinical Reserach conducted?

Raninier Clinical Reserach has 1 clinical trials on record. Their work covers Hyperlipidemia.

Is Raninier Clinical Reserach accredited by Crixeo Clinical Trials?

Raninier Clinical Reserach has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Raninier Clinical Reserach?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.